Back to search

Article

NNMT drives innate sensitivity to NAMPT inhibition in YAP-dependent stem-like/ mesenchymal prostate cancer

2025-05-02

Abstract excerpt

<h4>ABSTRACT</h4> Nicotinamide phosphoribosyltransferase (NAMPT) is the rate-limiting enzyme in the NAD+ salvage pathway and a promising therapeutic target in cancer. Resistance to NAMPT inhibitors, such as FK866, remains a key limitation to their clinical translation. While acquired resistance in cancer cell lines has been linked to target mutations, increased drug efflux and metabolic reprogramming, innate resi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7d7c6aa3-e597-5142-a6a7-beb123fa47d0
DOI
10.1101/2025.04.29.651153
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
NNMT drives innate sensitivity to NAMPT inhibition in YAP-dependent stem-like/ mesenchymal prostate cancerDOI 10.1101/2025.04.29.651153
Select a neighboring publication to make it the new centre.